CUMMINGS KEITH LAMONT (Chief Financial Officer) received a stock award from PLIANT THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/27/2025ACC: 0001746473-25-000011
Officer· Chief Financial Officer
Since Jun 2020
+169.95K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
169.95K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+56.65K
Price / share
—
Trade value
—
% of position
21.6%
1/23/2025
262.61K→319.26K
Total
Net shares
+56.65K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/23/2025 | A · Award | +56.65K | — | — | 21.6% | 262.61K | 319.26K |
| Total | +56.65K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
113.30K shares
Shares
+113.30K
Strike price
11.14
Held after
113.30K
Exercisable
—
1/23/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock113.30K shares | 1/23/2025 | A · Award | +113.30K | 11.14 | — | 113.30K |